Previous Article | Next Article 
Infection and Immunity, April 2000, p. 1840-1848, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Enhanced Hematopoietic Activity Accompanies
Parasite Expansion in the Spleen and Bone Marrow of Mice Infected
with Leishmania donovani
Sara E. J.
Cotterell,
Christian R.
Engwerda, and
Paul M.
Kaye*
Department of Infectious and Tropical
Diseases, London School of Hygiene and Tropical Medicine, London,
United Kingdom
Received 15 October 1999/Returned for modification 22 November
1999/Accepted 4 January 2000
 |
ABSTRACT |
In this study, we have analyzed hematopoietic activity in the
spleen, bone marrow, and blood of BALB/c and scid mice
infected with Leishmania donovani. Our analysis
demonstrates that infection induces a rapid but transient mobilization
of progenitor cells into the circulation, associated with elevated
levels of granulocyte/macrophage colony-stimulating factor (GM-CSF) and
MIP-1
. From 14 to 28 days postinfection, when parasite expansion
begins in the spleen and bone marrow, both the frequency and cell cycle
activity of hematopoietic progenitors, particulary CFU-granulocyte,
monocyte, are dramatically increased in these organs. This is
associated with increased accumulation of mRNA for GM-CSF, M-CSF, and
G-CSF, but not interleukin-3. Our data also illustrate that
hematopoietic activity, as assessed by changes in the frequency of
progenitor cell populations and their levels of cell cycle activity,
can be regulated in both a T-cell-independent and T-cell-dependent, as
well as in an organ-specific, manner. Collectively, these data add to
our knowledge of the long-term changes which occur in organs in which
L. donovani is able to persist.
 |
INTRODUCTION |
The regulation of hematopoietic
activity is an important homeostatic process of mammals. In the resting
state, the bone marrow represents the main site of hematopoiesis in
adult rodents, although a small percentage of myeloid precursors are
present in the spleen (18, 54). Regulation of hematopoietic
activity results from many extracellular matrix-cell and cell-cell
interactions between a variety of stromal cell populations and
hematopoietic stem cells and progenitor cells (7, 10, 12).
This cooperation is mediated through transmembrane adhesion molecules,
as well as the production of cytokines and chemokines with
hematopoietic activity (2, 6, 44, 47). Alterations in the
distribution of hematopoietic activity in the tissues may, however,
occur as a result of increased hematopoietic stress. In addition, local
changes in the balance of various cell lineages have also been
attributed to recruitment from the bone marrow via the peripheral
circulation. Increases in the hematopoietic activity of the spleen have
been observed following experimental murine infection with
Salmonella enterica serovar Typhimurium, Listeria
monocytogenes, Plasmodium yoelii, and Leishmania
major (33, 41, 54, 56, 57). However, there have been
fewer comparative studies of infection-induced changes in hematopoietic
activity in circumstances in which multiple tissues act as targets for
infection (25-31).
In both clinical and experimental visceral leishmaniasis,
Leishmania donovani and Leishmania infantum
amastigotes replicate in mononuclear phagocytes of the liver, spleen,
and bone marrow (1). Although the mechanisms of parasite
control and acquisition of immunity in the liver of BALB/c mice has
been extensively documented (15, 32, 55), recent interest
has focused on the course of infection in the spleen. Unlike the liver,
the spleen is persistently infected and suffers considerable
pathological disruption to its microanatomy 46, 48;
P. Gorak, unpublished data). In contrast, while the bone marrow has
long been recognized as a site of infection in mice (3, 23),
less is known about the relationship between parasite dynamics in this
organ, changes in cytokine and chemokine expression, and local
hematopoietic activity.
Therefore, we have conducted a comparative study of hematopoiesis in
the spleen, bone marrow, and peripheral blood of BALB/c mice following
infection with L. donovani. Our data indicate a marked
temporal association between changes in myelopoiesis, probably driven
by selected colony-stimulating factors (CSFs), and local parasite
expansion. Furthermore, tissue-specific expression of chemokines and
cytokines with hematopoietic activity is documented, and its
implications for the regulation of organ-specific responses to L. donovani infection in mice are discussed.
 |
MATERIALS AND METHODS |
Animals and parasites.
Female specific-pathogen-free BALB/c
mice were obtained from Tuck and Co. (Battlesbridge, United Kingdom).
C.B-17 scid mice were obtained from a breeding colony
maintained by Greg Bancroft at the London School of Hygiene and
Tropical Medicine, derived from a parental stock provided by C. Hetherington (National Institute for Medical Research, London, United
Kingdom). The mice were used at 8 to 10 weeks of age and housed under
conventional conditions, with food and water provided ad libitum. No
murine pathogens have been detected in our facility by routine sentinel
screening. Parasites of the Ethiopian strain of L. donovani
(LV9) were maintained by passage in Syrian hamsters as described
elsewhere (48). The mice were infected with 2 × 107 L. donovani cells intravenously in 200 µl
of RPMI or "sham" infected with an equivalent volume of
naïve hamster spleen homogenate.
Determination of tissue parasite burden.
The mice were
killed by cervical dislocation, and the livers, spleens, and femurs
were removed. The parasite load was determined from impression smears
following methanol fixation and Giemsa staining. For the spleen and
liver, the parasite burden was expressed as Leishman-Donovan units
(LDU), where LDU was equal to the number of parasites per 1,000 host
nuclei times the organ weight in milligrams (49). For bone
marrow, the parasite burden was determined both microscopically (as the
number of parasites per 1,000 host nuclei in smears) and by
limiting-dilution analysis on blood agar slopes (22).
Briefly, nutrient agar (3 g; Difco, Scientific Laboratory Supplies,
Ltd., Nottingham, United Kingdom) and NaCl (0.6 g; Sigma) were
dissolved in 100 ml of double-distilled H2O and autoclaved for 60 min. Glucose (5 ml; 30% [wt/vol] (Sigma) in
phosphate-buffered saline and 10 ml of citrated rabbit blood (Harlan
Seralab Ltd., Crawley Down, United Kingdom) were then added, and the
blood agar (50 µl) was dispensed into a flat-bottom 96-well plate
(Nunc; Marathon Laboratory Supplies, London, United Kingdom). The
plates were allowed to set at a 45° slant and were stored for up to 2 months in humidified boxes at 4°C before use. Three hours before the
addition of tissue samples, the plates were placed at 26°C. Single-cell suspensions from bone marrow were prepared in Dulbecco modified Eagle medium F12 nutrient mix (Gibco) plus 5% (vol/vol) heat-inactivated fetal calf serum plus 100 µg of streptomycin/ml and
100 µl of penicillin/ml. Serial dilutions of cell suspensions were
made, and 100 µl was added to each of 16 replicate wells. The plates
were cultured in humidified, 5% (vol/vol) CO2 incubators at 25 to 26°C for 9 days. After that time, the number of wells negative for parasite growth were scored using an inverted microscope. The logarithm of the fraction of negative wells was plotted against the
number of host cells plated at each serial dilution. The equation of
the best-fit line was generated by a
2 minimization
method, using a computer program adapted from reference 50 and supplied by E. Prina, Institut Pasteur,
Paris, France. The cell dilution yielding a fraction of 37% negative
wells for parasite growth gives an estimate of the reciprocal parasite frequency.
Assays of colony-forming precursors and progenitors.
Progenitor cell frequency in the bone marrow, spleen, and peripheral
blood was determined at various times postinfection (p.i.) by analysis
of their ability to produce colonies in semisolid methylcellulose
culture (18, 51). Single-cell suspensions were prepared from
spleens by passage through a 20-µm-pore-size nylon mesh, from bone
marrow by flushing with cold RPMI, and from heparinized peripheral
blood by Ficoll-Hypaque separation. The cells were washed in Iscove's
modified Dulbecco's medium (Gibco) supplemented with 100 µg of
penicillin/ml, 100 µg of streptomycin/ml, 20 mM sodium pyruvate, and
50 µM
-2-mercaptoethanol, and 70 µl (containing either 8 × 104 bone marrow cells, 1.2 × 106 spleen
cells, or 4 × 106 peripheral blood mononuclear cells
[PBMC]) was subsequently transferred to 4-ml Falcon tubes (Gibco).
Stem cell factor (SCF) (final concentration, 25 µg/ml; R & D Systems)
and hemin (bovine hemin chloride; final concentration, 100 µM; Sigma)
were added to each tube to give a final volume of 100 µl. Using a
1-ml syringe fitted with a 16-gauge, blunt-ended needle (Stem Cell
Technology), 900 µl of Methocult 3430 (0.1% [wt/vol]
methylcellulose, 30% [vol/vol] fetal calf serum, 1% [wt/vol]
bovine serum albumin, 100 µM 2-mercaptoethanol, 2 mM
L-glutamine, 2% [vol/vol] pokeweed mitogen-stimulated
murine spleen cell conditioned medium, and 3 U of recombinant human
erythropoietin [Epo]/ml; Stem Cell Technology) was taken up and
dispensed into each sample tube. The cells plus Methocult were mixed
thoroughly and allowed to stand at room temperature for 5 min to allow
air bubbles to rise to the top; 750 µl was carefully drawn into each syringe, and 250-µl triplicate samples were dispensed into the wells
of a 24-well tissue culture plate (Falcon). The final number of cells
plated per well was 2 × 104 bone marrow cells, 3 × 105 spleen cells, and 1 × 106 PBMC. In
some experiments, cultures were also supplemented with 50 to 150 µg
of sodium stibogluconate (Pentostam; Wellcome, Stevenage, United
Kingdom)/ml or 0.1 to 1.0 µg of Fungizone (Squibb and Sons, Princeton, Ga.)/ml. The plates were incubated for 7 days at 37°C in
5% (vol/vol) O2-5% (vol/vol) CO2. At later
time points in infection (days 28 and 56 p.i.), reduced numbers of
spleen cells (1.5 × 105) and bone marrow cells
(1.0 × 104) were plated per well to facilitate colony counting.
After 7 days of incubation at 37°C, the plates were examined
microscopically for colony counting. Colonies (assessed by eye to
contain greater than 50 cells) were scored as either CFU-granulocyte, erythrocyte, monocyte, megakaryocyte (GEMM; circular colonies with
characteristic brown-pink coloring); CFU-granulocyte, monocyte (GM;
spherical or dispersed clear or grey colonies); or burst-forming unit-erythrocyte (BFU-E); multicentered colonies with characteristic brown-pink coloring). To confirm identification, representative colonies were picked, cytospun onto glass microscope slides, and stained for hemoglobin content with a 5:1:1 mixture of 0.2% (wt/vol) O-dianisidine (Sigma) in methanol-3% (vol/vol) hydrogen
peroxide solution (Sigma)-1% (wt/vol) sodium nitroferricyanide
solution (Sigma) for 10 min at room temperature in the dark. The slides were rinsed under tap water and then counterstained with Giemsa stain.
Erythroid cell types could be identified microscopically as those
exhibiting a positive brown-yellow cytoplasmic reaction assessing the
presence of hemoglobin, in contrast to myeloid cells showing a
characteristic blue-grey cytoplasmic staining (51). Colony
numbers are expressed as the number of each progenitor type within a
fixed total number of cells, or within the whole tissue, based on the
ratio of the number of cells assayed to whole-organ cell counts.
Progenitor [3H]thymidine suicide assay.
To
determine the proliferative status of progenitor cells in the bone
marrow and spleen, the proportion of cells in S phase of the cell cycle
was determined (51). Single-cell suspensions were
resuspended in IMDM at 106 bone marrow cells/ml or
107 spleen cells/ml. Replicate 1-ml samples were either
untreated or pulsed with 50 µCi/ of l tritiated thymidine (specific
activity, 25 Ci/mmol; ICN, Irvine, United Kingdom)/ml, and samples were incubated at 37°C for 20 min. The samples were then chased with excess cold thymidine (20% [wt/vol] in ice-cold IMDM; Sigma). The
samples were then washed twice in IMDM and plated in colony assays, as
described above. Colony formation was evaluated after 7 days, and the
proportion of progenitor cells in S phase is expressed as the
percentage reduction in CFU formation in samples treated with tritiated
thymidine compared to controls.
Measurement of cytokine and chemokine mRNA accumulation.
mRNA was isolated and analyzed by a semiquantitative reverse
transcription (RT)-PCR assay as previously described (16). All PCR primers and probes were as described, with the addition of
granulocyte/macrophage colony-stimulating factor (GM-CSF)
(39), G-CSF (41), M-CSF (41), MIP-1
(45), and SCF (41) primers and probes. The
intensity of signals generated by mRNA encoding the housekeeping gene
for hypoxanthine-guanine phosphoribosyl transferase (HPRT) was used to
ensure approximately even loading of target cDNA into PCRs, and the
results were calculated as the intensity of signals generated by
cytokine products relative to signals generated by HPRT products for
each sample tested. The data are presented as the relative fold
increase in signal compared to control naïve mice analyzed at
each time point and represent the mean ± standard error for three
mice at each time point.
 |
RESULTS |
L. donovani accumulates in the bone marrow of BALB/c
mice.
We first wished to determine the relative course of
infection with L. donovani in the bone marrow and spleen of
BALB/c mice. As previously shown (48), after an initial lag
period during which parasite growth is not readily detectable, L. donovani amastigotes are detectable in increasing numbers in the
spleen and are maintained in the tissue throughout the 112 days
analyzed. The kinetics of parasite burden is similar irrespective of
whether data are expressed as LDU (which introduces a correction for
organ weight and thus represents total organ load) or as amastigotes
per 1,000 host cells (Fig. 1A). In the
bone marrow, the parasite burden was determined by two independent
means. Firstly, amastigotes were enumerated from Giemsa-stained bone
marrow tissue smears, in a fashion analogous to that used for the
spleen. Secondly, pooled femur samples were serially diluted onto blood
agar plates, allowing estimation of the parasite frequency by
limiting-dilution analysis (23). As shown in Fig. 1B,
parasite frequencies in the bone marrow, determined by either method,
were identical. These data confirm that the bone marrow serves as a
site of persistent infection and also indicate a striking similarity
with the spleen in the time of onset of rapid amastigote accumulaton.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
L. donovani causes a persistent infection in
the bone marrow of BALB/c mice. Mice were infected with 2 × 107 L. donovani amastigotes, and the parasite
burden was measured in the spleen (A) and bone marrow (B). In panel A,
the parasite burden was calculated as LDU ( ) or parasite frequency
per 1,000 host cells ( ), both determined from Giemsa-stained tissue
smears. In panel B, the parasite frequency was determined from tissue
smears ( ) or by limiting-dilution analysis ( ). The data represent
the mean ± standard error of the mean for three mice for tissue
smears ( ) or triplicate cultures using cells pooled from three
femurs in limiting-dilution assays. The data are representative of two
independent experiments.
|
|
An increased frequency of hematopoietic progenitors is observed
following L. donovani infection in BALB/c mice.
The
data presented above show that parasites persist within both the bone
marrow and spleen. To evaluate a possible association between parasite
burden in these tissues and changes in hematopoietic activity, we
assayed the frequency of progenitor cells capable of giving rise to
mature colonies in semisolid methylcellulose culture. To support
optimal in vitro colony growth, the cultures were supplemented with
erythropoietin, a source of CSFs, and SCF (see Materials and Methods).
Colony formation was not observed in the absence of these exogenous factors.
Colonies deriving from each progenitor cell type were readily observed
in cultures of naïve bone marrow, though CFU-GM were more
abundant than either BFU-E or CFU-GEMM (in a ratio of approximately 5:1:0.4, [Fig. 2]). Significant changes
in progenitor frequency were seen over the course of L. donovani infection. Elevated levels of all three types of colony
were observed by day 7 p.i., and they continued to rise until day
28 p.i., when they were present at approximately threefold
frequency compared to those from naïve mice. However, the ratio
of these three colony types remained similar (5:1.3:0.4).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
L. donovani infection is associated with
increased numbers of hematopoietic progenitors in the bone marrow of
BALB/c mice. Bone marrow (BM) cells from L. donovani-infected (hatched bars) and age-matched naïve
(open bars) mice were plated in hematopoietic methylcellulose colony
assays (see Materials and Methods). After 7 days, mature colonies were
scored as CFU-GEMM (A), CFU-GM (B), or BFU-E (C). The data represent
the mean ± standard error of the mean for triplicate wells and
are representative of two independent experiments. Significant
differences between naïve and infected groups are indicated:
*, P < 0.05; **, P < 0.005.
|
|
A lower frequency of progenitor cells was observed in the spleens of
naïve mice compared to that in the bone marrow (Fig. 3). Furthermore, the ratio of colony
types was different from that of bone marrow, with CFU-GM and BFU-E
present in almost equal frequency (1.3:1:0.1 for CFU-GM, BFU-E, and
CFU-GEMM, respectively). In the spleens of infected mice, significant
changes in hematopoietic activity were first detected at day 14 p.i. Whereas the numbers of BFU-E stabilized at this level, the numbers
of CFU-GM increased dramatically from day 14 to day 28 p.i. At day
28 p.i., CFU-GM were approximately tenfold more abundant on a per
cell basis than BFU-E (Fig. 3). The spleen undergoes significant
enlargement during the course of L. donovani infection
(48). When adjusted for total cell number, the
organ-specific capacity for myelopoiesis was increased 20- to 30-fold
at later times in infection (Table 1).
This analysis served to highlight both the extent to which progenitor
cell frequency increases and the selective expansion of myeloid
progenitors which occurs during infection.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
L. donovani infection is associated with
increased numbers of hematopoietic progenitors in the spleens of BALB/c
mice. Spleen cells from L. donovani-infected (hatched bars)
and age-matched naïve (open bars) mice were plated in
hematopoietic methylcellulose colony assays. After 7 days, mature
colonies were scored as CFU-GEMM (A), CFU-GM (B), or BFU-E (C). The
data represent the mean ± standard error of the mean for
triplicate wells and are representative of two independent experiments.
Significant statistical differences between naïve and infected
groups are indicated: *, P < 0.05; **,
P < 0.005; ***, P < 0.0005.
|
|
Rapid and transient increases in the number of progenitor cells in
the peripheral blood following L. donovani infection.
L. donovani infection fails to significantly alter the
frequency of monocytes, neutrophils, and lymphocytes in peripheral blood. For example, comparing naïve mice to those at day
56 p.i., neutrophils, monocytes, and lymphocytes represent
8.1 ± 0.4, 26.7 ± 1.1, and 62.8 ± 0.1% versus
9.2 ± 0.8, 25.8 ± 1.1, and 63.4 ± 1.0% of the total,
respectively. In contrast, progenitor cell activity was seen to vary
during the course of infection (Fig. 4).
A rapid, though transient, increase in the frequency of circulating CFU-GEMM, CFU-GM, and BFU-E was observed. This peaked at 5 h p.i. and declined to control levels by 72 h p.i. From day 7 p.i.
onwards, there was a second rise in progenitor cell numbers in the
peripheral blood, which was then maintained for the period of study. As
seen in the spleen, the relative increase at these later time points was most dramatic for CFU-GM. Therefore, during the course of L. donovani infection, there is a biphasic mobilization of
hematopoietic progenitor cells into the peripheral blood.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 4.
L. donovani infection induces biphasic
mobilization of hematopoietic progenitors into the peripheral blood of
BALB/c mice. Peripheral blood was removed from L. donovani-infected (hatched bars) and age-matched naïve
(open bars) mice at various times p.i., and PBMC were plated in
hematopoietic methylcellulose colony assays. After 7 days, mature
colonies were scored as CFU-GEMM (A), CFU-GM (B), or BFU-E (C). The
data represent the mean ± standard error of the mean for
triplicate wells and are representative of two independent experiments.
Significant statistical differences between naïve and infected
groups are indicated: *, P < 0.05; **,
P < 0.005; ***, P < 0.0005.
|
|
Increases in splenic progenitor cell numbers are independent of the
continual presence of parasites in colony assays.
The data shown
above indicate that both parasite burden and the frequency of
hematopoietic progenitor cells rise dramatically in the spleen from day
14 p.i. As our analysis of progenitor cells is based upon
unfractionated cell populations, which contained variable numbers of
infected macrophages, we wished to exclude the possibility that
parasites per se influenced the in vitro colony-forming potential of
progenitor cells. Therefore, we repeated these assays in the presence
and absence of antileishmanial drugs. At the concentrations used,
neither Pentostam nor Fungizone had an effect on spleen cell viability
while they were able to kill 97% of L. donovani within
24 h (from 34 amastigotes/100 host cells to 1/100, as determined
from cytospin preparations). As shown in Fig.
5, these drugs did not affect the number
of colonies derived from either naïve or infected spleen cells.
Thus, the presence of amastigotes or infected macrophages appears to
have little influence on colony formation in vitro in the presence of
optimal levels of growth factors.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
The presence of living parasites does not affect colony
formation in methylcellulose cultures. Spleens were removed from
age-matched naïve mice (A) and mice infected with L. donovani for 28 days (B). Replicate samples were plated in
hematopoietic methylcellulose colony assays with no additions (open
bars) or in the presence of 1 µg of Fungizone (hatched bars)/ml or
150 µg of Pentostam (cross-hatched bars)/ml. After 7 days, mature
colonies were scored. The data represent the mean ± standard
error of the mean for triplicate wells and are representative of two
independent experiments.
|
|
Frequency of progenitor cells in the cell cycle is increased during
L. donovani infection of BALB/c mice.
In vitro colony
assays determine the frequency of progenitor cells capable of
proliferating in response to hematopoietic growth or antiapoptotic
factors. However, they do not directly evaluate the actual
hematopoietic activity at the time of sacrifice. In order to address
this issue, we performed suicide selection experiments with bone marrow
and spleen cells from naïve and infected mice. Progenitor cells
entering S phase during the pulse with radioactive thymidine
subsequently die, and the percentage of progenitor cells in S phase of
the cell cycle can be determined from the decrease in mature colony
numbers after 7 days (51). As shown in Table 2, a fraction of each progenitor cell
population was actively proliferating in the bone marrow of
naïve BALB/c mice. In the spleens of naïve mice, the
proportion of progenitor cells in cell cycle was much lower than that
observed in the bone marrow, consistent with a majority of
hematopoiesis occurring in the bone marrow in the resting state
(18). Furthermore, the percentages of myeloid and erythroid
colony-forming cells in S phase were comparable in the spleen, compared
to the greater level of myeloid activity in the bone marrow. Following
infection with L. donovani, the percentages of progenitor
cells in S phase in both the spleen and bone marrow increased. In the
bone marrow, the percentage of each progenitor population in S phase
was increased approximately 1.5-fold as a result of infection. In
contrast, the relative increase of cells in the cell cycle was
considerably greater in the spleen (8-, 14-, and 8-fold increases in
CFU-GEMM, CFU-GM, and BFU-E, respectively). The combination of
selective expansion of CFU-GM progenitors (Fig. 3 and Table 1) and
their active proliferation (Table 2) indicates that splenic
myelopoiesis is specifically and extensively increased as a result of
L. donovani infection.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
L. donovani infection results in a
differential increase in the proliferative status of progenitor cells
in BALB/c and scid mice
|
|
scid mice fail to increase hematopoietic activity in
the spleen following L. donovani infection.
To examine
the role of acquired immunity in the regulation of hematopoiesis during
L. donovani infection, we also examined progenitor cell
proliferation in scid mice (4, 16). Although the
frequency of progenitors is increased in the bone marrow and spleen of
naïve scid mice, absolute numbers per organ are
comparable to those in coisogenic BALB/c mice (14) (data not
shown). At day 42 p.i., when scid mice have a
significantly higher parasite burden in the spleen than BALB/c mice
(900 ± 36 versus 130 ± 9 amastigotes/1,000 spleen cells,
respectively; P < 0.001), scid mice failed
to upregulate the number of splenic CFU-GM as a result of L. donovani infection [(66.3 ± 2.3) × 103
versus (74.0 ± 2.7) × 103
CFU-GM/108 spleen cells in naïve and infected mice
respectively]. Furthermore, no increase in the percentage of
progenitor cells in the cell cycle was observed in the spleens of
scid mice following infection with L. donovani
(Table 2). In contrast, there was a significant increase in the number
of progenitors in the cell cycle in the bone marrow of infected
scid mice. This was of the same order of magnitude
(approximately 1.5-fold) as that seen in BALB/c mice at this time.
Hence, the spleen and bone marrow of scid mice differ in
their ability to regulate hematopoiesis following L. donovani infection.
Increases in progenitor cell proliferation are associated with
increased hematopoietic growth factor mRNA accumulation.
The
above-mentioned experiments indicate that hematopoiesis is enhanced to
varying degrees in the bone marrow and spleen of L. donovani-infected BALB/c and scid mice. Given that
hematopoiesis is stimulated and regulated by a number of CSFs,
cytokines, and chemokines, the effect of L. donovani
infection on the accumulation of mRNA for some of these factors was
examined. The majority of factors analyzed were expressed
constitutively in the bone marrow and spleen in both strains,
consistent with active hematopoiesis occurring in these organs in the
resting state. However, expression of
IP-10 was low or undetectable,
and expression of interleukin 3 (IL-3) was also minimal. Tables
3 and 4
summarize the data from two independent experiments in which we
measured the increases in mRNA accumulation observed in individual
BALB/c and scid mice at various times p.i. L. donovani infection induced a rapid accumulation of mRNA for GM-CSF
and MIP-1
in the bone marrow of both BALB/c and scid mice
(Table 3), suggesting that this represents a direct T-cell-independent
response to infection in this organ. In the spleen (Table 4),
accumulation of mRNA at 5 h p.i. was only observed for MIP-1
and not GM-CSF, again in both strains of mice. Surprisingly, given
previous studies of chemokine expression in the liver (9), neither MCP-1 nor
IP-10 mRNA accumulation was induced in either spleen or bone marrow immediately following infection. In the bone
marrow of BALB/c mice, no significant changes in mRNA accumulation were
subsequently observed until days 28 to 42 p.i. In the spleen significant levels of GM-CSF and M-CSF were only detectable at day
14 p.i. in one of two independent experiments. By days 28 to
42 p.i., significant increases in accumulation of mRNA for the
growth factors G-CSF, M-CSF, and GM-CSF occurred in the bone marrow and
spleens of BALB/c mice, correlating with late expansion of myeloid
progenitor cell numbers and proliferative capacity (Fig. 2 and 3 and
Table 2). In contrast, while later increases in the expression of CSFs
were observed in the femurs of scid mice, accumulation of
mRNA for myeloid growth factors was not apparent in the spleen. This
restriction of CSF production to the bone marrow microenvironment may
account for the selective inability of scid mice to increase
splenic progenitor proliferation following L. donovani
infection (Table 2). Together, these data indicate that the expression
of cytokines and chemokines with hematopoietic activity is subject to
both T-cell-dependent and T-cell-independent, as well as
tissue-specific, regulation.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
L. donovani infection of BALB/c and
scid mice induces the accumulation of mRNA for hematopoietic
growth factors in the bone marrow
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
L. donovani infection of BALB/c and
scid mice induces the accumulation of mRNA for hematopoietic
growth factors in the spleen
|
|
 |
DISCUSSION |
L. donovani infection of genetically susceptible mice
results in a resolving parasite burden in the liver and a relatively persistent infection in the spleen and bone marrow (references 23 and 48 and this study). Here,
we have characterized for the first time the local changes in
hematopoietic activity in tissues which harbor persistent parasites and
compared it with both parasite dynamics and the evolution of cytokine
and chemokine responses in these organs. While the picture which
emerges is undoubtedly one of extreme complexity, there are
nevertheless a number of specific observations which warrant further comment.
First, L. donovani infection caused a rapid (5-h), yet
transient, increase in progenitor cell frequency in the blood but not the spleen or bone marrow. Rapid mobilization of hematopoietic stem
cells and progenitor cells from the bone marrow to the peripheral blood
has also been described following the administration of lipopolysaccharide (18), as well as a variety of cytokines, including GM-CSF (42), G-CSF (34, 36), SCF
(5), IL-8 (22), IL-12 (20), and
MIP-1
(6). Although the mechanisms of cytokine-induced
cellular mobilization have not been fully elucidated, the modification
of adhesive interactions with stromal cells is thought to play a role
(40, 53). However, the mechanisms of mobilization may differ
among eliciting agents (43). Mobilization of progenitor
cells immediately following L. donovani infection correlated
with an increase in femoral mRNA accumulation for GM-CSF and MIP-1
at 5 h p.i., suggesting these two factors play a crucial role
following L. donovani infection. Others have also described transient progenitor cell mobilization in response to GM-CSF
(42). Although mobilization of stem cells and progenitors
following cytokine or lipopolysaccharide administration is generally
associated with a redistribution of hematopoietic precursors to the
spleen (18, 34, 42), we were unable to detect any increases
in spleen cell progenitor numbers within the first week of infection. However, since mRNA accumulation for MIP-1
was also induced in the
spleens of infected mice, mobilization and recruitment of progenitor
cells may balance each other in this organ. These data suggest a
fundamental difference in tissue recruitment and activation of
progenitor cells following L. donovani infection compared to that reported in other models.
Second, our data provide further evidence of tissue-specific regulation
of cytokine and chemokine expression. We have previously demonstrated
that L. donovani infection triggered a transient T-cell-independent chemokine response in the livers of infected mice.
This response, largely mediated by Kupffer cells, involves early
production of MIP-1
, MCP-1, and
IP-10 (9). It is
apparent from the current study that while T-cell-independent responses also occur in other tissues, they are more restricted in nature. Thus,
both bone marrow and spleen produce MIP-1
yet fail to accumulate significant levels of mRNA for MCP-1 or
IP-10. Furthermore, whereas there is T-cell-independent expression of GM-CSF in the bone marrow (Table 3), it is absent from the spleen (Table 4). The functional significance of these findings remains to be fully established. However, it is of interest that we recently postulated that
IP-10 is
the key chemokine required to initiate effective host protective responses in the liver (9) and that in two organs in which parasites persist, we have failed to detect significant levels of this
chemokine. Furthermore, we have recently demonstrated that L. donovani infection of a bone marrow-derived stromal macrophage line significantly affects its ability to regulate the hematopoietic activity of progenitor populations, under conditions where growth factors are limiting (8). Amastigote infection of these
stromal macrophages selectively enhances CFU-GM production by a
mechanism involving GM-CSF acting in concert with tumor necrosis factor alpha. Although MIP-1
is also produced by these cells, antibody neutralization experiments indicate that this chemokine plays no role
in supporting colony growth in vitro. These data suggest that the major
role of MIP-1
is, as discussed above, related to progenitor cell mobilization.
Third, as infection progressed the frequencies of CFU-GEMM, CFU-GM, and
BFU-E increased in the bone marrow, spleen, and peripheral blood. This
correlated with increased progenitor cell cycling in both the spleen
and bone marrow and increased expression of mRNA for the growth factors
GM-CSF, G-CSF, and M-CSF. These CSFs, together with IL-3, are usually
described as the dominant molecules controlling the production and
maturation of granulocytes (IL-3, GM-CSF, and G-CSF), and monocytes
(IL-3, GM-CSF, and M-CSF) from more primitive, multipotential
precursors (28, 52). Nevertheless, we have been unable to
detect the accumulation of IL-3 mRNA in either the spleens or bone
marrow of mice infected with L. donovani. Similarly, IL-3
protein has not been detected either in direct ex vivo cultures of
spleen cells from long-term-infected mice (S. E. J. Cotterell, unpublished data) or in restimulation assays with
leishmanial antigens (21). Hence, in contrast to the
significant involvement of IL-3 in visceralizing stages of L. major infection (24), this cytokine plays a limited, if
any, role in the alteration of hematopoietic activity caused by
L. donovani infection. Interestingly, while the fold
increase in expression of mRNA for each CSF was similar in the bone
marrow and spleen, progenitor cell frequency and proliferative status
was increased to a greater extent in the spleen than the bone marrow.
Moreover, the myeloid progenitor number was selectively increased in
the spleen, in comparison to similar increases in myeloid and erythroid
hematopoiesis observed in the bone marrow. The significance of these
observations is under further investigation.
Finally, this study reveals a striking correlation between increased
hematopoietic activity and parasite growth in both the spleen and bone
marrow. The "safe-target" hypothesis, where increased numbers of
immature myeloid cells provide a site for rapid multiplication of
amastigotes, has been frequently applied to infections with L. major (13, 33). In this model, both susceptibility to
infection and myelopoiesis are regulated by IL-3 and GM-CSF (17,
19, 24), and the parasite has a tropism for immature myeloid
cells (11, 33). In contrast, L. donovani
infection occurs most readily in mature macrophage populations
(11), IL-3 is limiting during infection (reference
21 and this report), and GM-CSF is required for
resistance in the liver (35). Therefore, the increased level of myelopoiesis, if biologically relevant, may not serve the same function in these two models. In addition, it should be noted that
parasite growth can be significant even in the absence of increases in
local hematopoietic activity, as shown here in the spleens of
scid mice. Investigation into the precise relationship between hematopoietic activity and parasite growth is hampered by the
difficulties associated with long-term cytokine neutralization in vivo
and the redundancy of hematopoietic growth factors in gene-targeted
mice (37, 38). Nevertheless, the future development of
conditional or cell-type-specific mutants should aid in addressing this question.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Wellcome Trust and the
British Medical Research Council. S.E.J.C. is a recipient of a Wellcome
Trust Prize Studentship, and C.R.E. is the recipient of a Wellcome
Trust Career Development Award.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT United Kingdom. Phone: 44 171 927 2390. Fax: 44 171 323 5687. E-mail:
paul.kaye{at}lshtm.ac.uk.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Baker, R.,
P. Chiodini, and P. M. Kaye.
1999.
Leishmaniasis, p. 212-234.
In
D. Geraint James, and A. Zumla (ed.), The granulomatous disorders. Cambridge University Press, Cambridge, United Kingdom.
|
| 2.
|
Behringer, D.,
V. Kresin,
R. Henschler,
R. Mertelsmann, and A. Lindemann.
1997.
Cytokine and chemokine production by CD34+ haemopoietic progenitor cells: detection in single cells.
Br. J. Haematol.
97:9-14[CrossRef][Medline].
|
| 3.
|
Blackwell, J. M.,
C. Hale,
M. B. Roberts,
O. M. Ulczak,
F. Y. Liew, and J. G. Howard.
1985.
An H-11-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice.
Immunogenetics
21:385-395[CrossRef][Medline].
|
| 4.
|
Bosma, G. C.,
R. P. Custer, and M. J. Bosma.
1983.
A severe combined immunodeficiency mutation in the mouse.
Nature
301:527-530[CrossRef][Medline].
|
| 5.
|
Briddell, R. A.,
C. A. Hartley,
K. A. Smith, and I. K. McNiece.
1993.
Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential.
Blood
82:1720-1723[Abstract/Free Full Text].
|
| 6.
|
Broxmeyer, H. E.,
C. R. Mantel, and S. M. Aronica.
1997.
Biology and mechanisms of action of synergistically stimulated myeloid progenitor cell proliferation and suppression by chemokines.
Stem Cells
15:69-77.
|
| 7.
|
Clark, B. R.,
J. T. Gallagher, and T. M. Dexter.
1992.
Cell adhesion in the stromal regulation of haemopoiesis.
Baillieres Clin. Haematol.
5:619-652[Medline].
|
| 8.
| Cotterell, S., C. Engwerda, and P. Kaye.
Leishmania donovani infection of bone marrow stromal marcrophages
selectively enhances myelopoiesis, by a mechanism involving GM-CSF and
TNF-alpha. Blood, in press.
|
| 9.
|
Cotterell, S. E.,
C. R. Engwerda, and P. M. Kaye.
1999.
Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-independent manner.
Eur. J. Immunol.
29:203-214[CrossRef][Medline].
|
| 10.
|
Crocker, P. R., and S. Gordon.
1985.
Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow.
J. Exp. Med.
162:993-1014[Abstract/Free Full Text].
|
| 11.
|
Davies, E. V.,
A. M. Singleton, and J. M. Blackwell.
1988.
Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations.
Infect. Immun.
56:1128-1134[Abstract/Free Full Text].
|
| 12.
|
Dexter, T. M.,
T. D. Allen, and L. G. Lajtha.
1977.
Conditions controlling the proliferation of haemopoietic stem cells in vitro.
J. Cell. Physiol.
91:335-344[CrossRef][Medline].
|
| 13.
|
Djoko-Tamnou, J.,
C. Leclerc,
F. Modabber, and L. Chedid.
1981.
Studies on visceral Leishmania tropica infection in BALB/c mice. I. Clinical features and cellular changes.
Clin. Exp. Immunol.
46:493-498[Medline].
|
| 14.
|
Dorshkind, K.,
G. M. Keller,
R. A. Phillips,
R. G. Miller,
G. C. Bosma,
M. O'Toole, and M. J. Bosma.
1984.
Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.
J. Immunol.
132:1804-1808[Abstract].
|
| 15.
|
Engwerda, C. R.,
M. L. Murphy,
S. E. Cotterell,
S. C. Smelt, and P. M. Kaye.
1998.
Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Eur. J. Immunol.
28:669-680[CrossRef][Medline].
|
| 16.
|
Engwerda, C. R.,
S. C. Smelt, and P. M. Kaye.
1996.
An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Exp. Parasitol.
84:195-202[CrossRef][Medline].
|
| 17.
|
Feng, Z. Y.,
J. Louis,
V. Kindler,
T. Pedrazzini,
J. F. Eliason,
R. Behin, and P. Vassalli.
1988.
Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3.
Eur. J. Immunol.
18:1245-1251[Medline].
|
| 18.
|
Gao, J. L.,
T. A. Wynn,
Y. Chang,
E. J. Lee,
H. E. Broxmeyer,
S. Cooper,
H. L. Tiffany,
H. Westphal,
J. Kwon-Chung, and P. M. Murphy.
1997.
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1.
J. Exp. Med.
185:1959-1968[Abstract/Free Full Text].
|
| 19.
|
Greil, J.,
B. Bodendorfer,
M. Rollinghoff, and W. Solbach.
1988.
Application of recombinant granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis.
Eur. J. Immunol.
18:1527-1533[Medline].
|
| 20.
|
Jackson, J. D.,
Y. Yan,
M. J. Brunda,
L. S. Kelsey, and J. E. Talmadge.
1995.
Interleukin-12 enhances peripheral hematopoiesis in vivo.
Blood
85:2371-2376[Abstract/Free Full Text].
|
| 21.
|
Kaye, P. M.,
A. J. Curry, and J. M. Blackwell.
1991.
Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
J. Immunol.
146:2763-2770[Abstract].
|
| 22.
|
Laterveer, L.,
I. J. Lindley,
M. S. Hamilton,
R. Willemze, and W. E. Fibbe.
1995.
Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability.
Blood
85:2269-2275[Abstract/Free Full Text].
|
| 23.
|
Leclercq, V.,
M. Lebastard,
Y. Belkaid,
J. Louis, and G. Milon.
1996.
The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci.
J. Immunol.
157:4537-4545[Abstract].
|
| 24.
|
Lelchuk, R.,
R. Graveley, and F. Y. Liew.
1988.
Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
Cell Immunol.
111:66-76[CrossRef][Medline].
|
| 25.
|
Marchal, G., and G. Milon.
1986.
Control of hemopoiesis in mice by sensitized L3T4+ Lyt2-lymphocytes during infection with bacillus Calmette-Guerin.
Proc. Natl. Acad. Sci. USA
83:3977-3981[Abstract/Free Full Text].
|
| 26.
|
Marchal, G., and G. Milon.
1981.
Decreased erythropoiesis: the origin of the BCG induced anaemia in mice.
Br. J. Haematol.
48:551-560[Medline].
|
| 27.
|
Marchal, G., and G. Milon.
1984.
Numeration of DTH-mediating T lymphocytes in mice under optimal titration conditions.
Ann. Immunol. (Paris).
135C:353-364.
|
| 28.
|
Metcalf, D.
1991.
Control of granulocytes and macrophages: molecular, cellular, and clinical aspects.
Science
254:529-533[Abstract/Free Full Text].
|
| 29.
|
Milon, G.,
G. Marchal, and M. Lebastard.
1984.
BDG infection in mice: a model for in vivo analysis of T lymphocytes as regulators of haemopoiesis.
Ann. Immunol.
135C:291-294.
|
| 30.
|
Milon, G.,
P. Goossens, and G. Marchal.
1985.
Role of T lymphocytes during murine BCG infection, p. 553-559.
In
R. van Furth (ed.), Mononuclear phagocytes characteristics, physiology and function. Martinus Nijhoff Publishers, Boston, Mass.
|
| 31.
|
Milon, G.,
M. Gheorghiu,
M. Lagranderie,
M. Lebastard, and G. Marchal.
1984.
BCG-induced anaemia in mice: no direct effect of the growth of bacilli.
Ann. Immunol. (Paris)
135C:195-204.
|
| 32.
|
Miralles, G. D.,
M. Y. Stoeckle,
D. F. McDermott,
F. D. Finkelman, and H. W. Murray.
1994.
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis.
Infect. Immun.
62:1058-1063[Abstract/Free Full Text].
|
| 33.
|
Mirkovich, A. M.,
A. Galelli,
A. C. Allison, and F. Z. Modabber.
1986.
Increased myelopoiesis during Leishmania major infection in mice: generation of `safe targets,' a possible way to evade the effector immune mechanism.
Clin. Exp. Immunol.
64:1-7[Medline].
|
| 34.
|
Molineux, G.,
Z. Pojda, and T. M. Dexter.
1990.
A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor.
Blood
75:563-569[Abstract/Free Full Text].
|
| 35.
|
Murray, H. W.,
J. S. Cervia,
J. Hariprashad,
A. P. Taylor,
M. Y. Stoeckle, and H. Hockman.
1995.
Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.
J. Clin. Investig.
95:1183-1192.
|
| 36.
|
Neben, S.,
K. Marcus, and P. Mauch.
1993.
Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor.
Blood
81:1960-1967[Abstract/Free Full Text].
|
| 37.
|
Nilsson, S. K.,
G. J. Lieschke,
C. C. Garcia-Wijnen,
B. Williams,
D. Tzelepis,
G. Hodgson,
D. Grail,
A. R. Dunn, and I. Bertoncello.
1995.
Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse.
Blood
86:66-72[Abstract/Free Full Text].
|
| 38.
|
Nishinakamura, R.,
A. Miyajima,
P. J. Mee,
V. L. Tybulewicz, and R. Murray.
1996.
Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.
Blood
88:2458-2464[Abstract/Free Full Text].
|
| 39.
|
O'Garra, A.,
G. Stapleton,
V. Dhar,
M. Pearce,
J. Schumacher,
H. Rugo,
D. Barbis,
A. Stall,
J. Cupp,
K. Moore, et al.
1990.
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10.
Int. Immunol.
2:821-832[Abstract/Free Full Text].
|
| 40.
|
Papayannopoulou, T.,
C. Craddock,
B. Nakamoto,
G. V. Priestley, and N. S. Wolf.
1995.
The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen.
Proc. Natl. Acad. Sci. USA
92:9647-9651[Abstract/Free Full Text].
|
| 41.
|
Peterson, V. M.,
J. J. Adamovicz,
T. B. Elliott,
M. M. Moore,
G. S. Madonna,
W. E. Jackson, III,
G. D. Ledney, and W. C. Gause.
1994.
Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers.
J. Immunol.
153:2321-2330[Abstract].
|
| 42.
|
Pojda, Z.,
G. Molineux, and T. M. Dexter.
1989.
Effects of long-term in vivo treatment of mice with purified murine recombinant GM-CSF.
Exp. Hematol.
17:1100-1104[Medline].
|
| 43.
|
Pruijt, J. F.,
Y. van Kooyk,
C. G. Figdor,
I. J. Lindley,
R. Willemze, and W. E. Fibbe.
1998.
Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8.
Blood
91:4099-4105[Abstract/Free Full Text].
|
| 44.
|
Quesenberry, P.,
E. McElrath,
E. Buxton,
E. Kittler,
R. Crittendon, and D. Temeles.
1990.
Constitutive production of multiple hemopoietic growth factors by murine Dexter stroma.
Blood
76:161a.
|
| 45.
|
Rhoades, E. R.,
A. M. Cooper, and I. M. Orme.
1995.
Chemokine response in mice infected with Mycobacterium tuberculosis.
Infect. Immun.
63:3871-3877[Abstract].
|
| 46.
|
Saha, B.,
H. Nanda-Roy,
A. Pakrashi,
R. N. Chakrabarti, and S. Roy.
1991.
Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis.
Eur. J. Immunol.
21:577-581[Medline].
|
| 47.
|
Simmons, P. J.,
J. P. Levesque, and A. C. Zannettino.
1997.
Adhesion molecules in haemopoiesis.
Baillieres Clin. Haematol.
10:485-505[Medline].
|
| 48.
|
Smelt, S. C.,
C. R. Engwerda,
M. McCrossen, and P. M. Kaye.
1997.
Destruction of follicular dendritic cells during chronic visceral leishmaniasis.
J. Immunol.
158:3813-3821[Abstract].
|
| 49.
|
Stauber, L. A.
1958.
Host resistance to the Khartoum strain of Leishmania donovani.
Rice Institute Pamphlet.
45:80-86.
|
| 50.
|
Taswell, C.
1981.
Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.
J. Immunol.
126:1614-1619[Abstract].
|
| 51.
|
Testa, N. J., and T. M. Dexter.
1999.
The regulation of haematopoietic cell production, p. 1-12.
In
L. V. A. Hoffbrand, S. M. Lewis, and E. G. D. Tuddenham (ed.), Postgraduate hematology. Butterworth/Heinemann, Oxford, United Kingdom.
|
| 52.
|
Valledor, A. F.,
F. E. Borras,
M. Cullell-Young, and A. Celada.
1998.
Transcription factors that regulate monocyte/macrophage differentiation.
J. Leukoc. Biol.
63:405-417[Abstract].
|
| 53.
|
Vermeulen, M.,
F. Le Pesteur,
M. C. Gagnerault,
J. Y. Mary,
F. Sainteny, and F. Lepault.
1998.
Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells.
Blood
92:894-900[Abstract/Free Full Text].
|
| 54.
|
Weiss, L.
1989.
Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy.
Am. J. Trop. Med. Hyg.
41:144-160.
|
| 55.
|
Wilson, M. E.,
M. Sandor,
A. M. Blum,
B. M. Young,
A. Metwali,
D. Elliott,
R. G. Lynch, and J. V. Weinstock.
1996.
Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi.
J. Immunol.
156:2231-2239[Abstract].
|
| 56.
|
Young, A. M., and C. Cheers.
1986.
Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice.
Cell Immunol.
97:227-237[CrossRef][Medline].
|
| 57.
|
Zhan, Y.,
G. J. Lieschke,
D. Grail,
A. R. Dunn, and C. Cheers.
1998.
Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice.
Blood
91:863-869[Abstract/Free Full Text].
|
Infection and Immunity, April 2000, p. 1840-1848, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Engwerda, C. R., Ato, M., Cotterell, S. E. J., Mynott, T. L., Tschannerl, A., Gorak-Stolinska, P. M. A., Kaye, P. M.
(2002). A Role for Tumor Necrosis Factor-{alpha} in Remodeling the Splenic Marginal Zone during Leishmania donovani Infection. Am. J. Pathol.
161: 429-437
[Abstract]
[Full Text]
-
Murray, H. W.
(2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother.
45: 2185-2197
[Full Text]